scispace - formally typeset
Open Access

ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, +3 more
- Vol. 70, Iss: 1, pp 1-84
About
The article was published on 2017-01-01 and is currently open access. It has received 3603 citations till now. The article focuses on the topics: Management of atrial fibrillation.

read more

Citations
More filters
Journal ArticleDOI

N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation

TL;DR: NT-proBNP was increased in individuals with newly detected AF and could be used to correctly select individuals that benefit most from AF screening, suggesting that 35% fewer participants would need to be screened when applied to systematic AF screening.
Journal ArticleDOI

Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice

TL;DR: A novel role is identified for CXCR-2 in driving monocyte infiltration of the atria, which accelerates atrial remodeling and AF after hypertension and may serve as a new therapeutic strategy for AF.
Journal ArticleDOI

A systematic review of patient-reported outcomes associated with the use of direct-acting oral anticoagulants

TL;DR: This systematic review aimed to analyse the impact of PROs in patients on direct oral anticoagulant treatment, prescribed for any indication, using controlled trials (CT) and real‐world observational studies (OS).
Journal ArticleDOI

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.

TL;DR: In patients with AF, of 268 unique biomarkers, the 6 biomarkers most strongly associated with subsequent ischemic stroke/systemic embolism represent fibrosis/remodeling (matrix metalloproteinase‐9 and soluble suppression of tumorigenesis 2), cardiac dysfunction (NT‐proBNP), vascular calcification (osteopontin), metabolism (sortilin), and mucosal integrity/ischemia (trefoil factor‐3).
Journal ArticleDOI

Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.

TL;DR: Direct oral anticoagulants have been proposed as a more convenient alternative to vitamin K antagonists (VKAs), which are commonly associated with poor treatment persistence in non‐valvular atrial fibrillation (nv‐AF).
References
More filters
Journal ArticleDOI

2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Giuseppe Mancia, +89 more
TL;DR: In this article, a randomized controlled trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly people was presented. But the authors did not discuss the effect of the combination therapy in patients living with systolic hypertension.
Journal ArticleDOI

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

TL;DR: The TOAST stroke subtype classification system is easy to use and has good interobserver agreement and should allow investigators to report responses to treatment among important subgroups of patients with ischemic stroke.
Journal ArticleDOI

Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins

TL;DR: The pulmonary veins are an important source of ectopic beats, initiating frequent paroxysms of atrial fibrillation and these foci respond to treatment with radio-frequency ablation.
Related Papers (5)